National Cancer Statistics in Korea, 2014

Transcription

1 National Cancer Statistics in Korea, Korea Central Cancer Registry

2 Cancer Incidence in Korea, 2014

3 National Cancer Incidence, 2014

4 Trends in Cancer Incidence by Sex and Year * Dark colored bars represent thyroid cancer incident cases

5 Comparison of cancer cases and rates between 2013 and 2014

6 Number of cases by cancer sites ( )

7 Distribution by Cancer Sites, 2014

8 Distribution by Cancer Sites and Sex, 2014

9 Trends in Age-standardized Incidence Rate: All Cancer Sites, Trend1 Trend2 Sex Period APC (%) Period APC (%) Both sexes * * Male * * Female * * * P < 0.05 * Age-standardized incidence Rate (ASR) was standardized to the Korean standard population (year 2000)

10 Trends in Age-standardized Incidence Rate: Excluding Thyroid, Trend1 Trend2 sex Period APC (%) Period APC (%) Both Sexes * * Male * * Female * * P < 0.05 * Age-standardized incidence Rate (ASR) was standardized to the Korean standard population (year 2000)

11 Trends in Major Cancers 1) : Both Sexes, Cancer sites Period Trend 1 Trend 2 APC (%) Period APC (%) Thyroid * * Stomach * Colon and rectum * * Lung * Breast * * Liver * * Prostate * ) Major sites selected based on 2014 crude rates * Age-standardized incidence Rate (ASR) was standardized to the Korean standard population (year 2000) * P < 0.05

12 Trends in Major Cancers 1) : Male, Cancer sites Period Trend 1 Trend 2 APC (%) Period APC (%) Stomach * * Lung * Colon and rectum * * Liver * * Prostate * Thyroid * * 1) Major sites selected based on 2014 crude rates * Age-standardized incidence Rate (ASR) was standardized to the Korean standard population (year 2000) * P < 0.05

13 Trends in Major Cancers 1) : Female, Cancer sites Period Trend 1 Trend 2 APC (%) Period APC (%) Thyroid * * Breast * * Colon and rectum * * Stomach * Lung * Cervix uteri * 1) Major sites selected based on 2014 crude rates * Age-standardized incidence Rate (ASR) was standardized to the Korean standard population (year 2000) Liver * * * P < 0.05

14 Cumulative Risk of Cancer in Korea, 2014 Male 38.7% (79 years*) (2 out of 5) Female 33.1% (85 years*) (1 out of 3) * Life Expectancy, 2014 (Source : Statistics Korea )

15 International Comparison of Age-Standardized Incidence Rates 1) by Sex 1) The incidence rates of all cancers excluding non-melanoma skin cancer(c44) are age-adjusted using the world standard population to compare globally 2) Estimated cancer incidence rate for 2012 using the cancer registration data by the year 2007 (GLOBOCAN 2012, IARC, 2013) 3) Korea: Cancer Incidence data, 2014 (Published in 2016)

16 International Comparison of Age-Standardized Incidence Rates: Male Rank * Korea 1) (2014) Estimated rates (2012) 2) (Unit: rate per 100,000) Japan USA UK All Cancers All Cancers All Cancers All Cancers Excluding Thyroid Excluding Thyroid Excluding Thyroid Excluding Thyroid Stomach 52.7 Stomach 45.7 Prostate 98.2 Prostate Lung 43.7 Colon and rectum 42.1 Lung 44.2 Colon and rectum Colon and rectum 42.6 Lung 38.8 Colon and rectum 28.5 Lung Lung 31.4 Prostate 30.4 Bladder 19.6 Melanoma of skin Liver 25.6 Liver 14.6 Melanoma of skin 16.8 Non-Hodgkin Lymphoma Prostate 17.3 Esophagus 11.1 Kidney 15.9 Kidney Thyroid 8.4 Pancreas 10.6 Non-Hodgkin Lymphoma 14.7 Esophagus Pancreas 8.4 Bladder 9.8 Leukemia 10.3 Leukemia Kidney 8.4 Non-Hodgkin Lymphoma 7.9 Liver 9.8 Bladder Non-Hodgkin Lymphoma 8.1 Kidney 7.8 Pancreas 8.6 Pancreas 6.8 1) The incidence rates of all cancers excluding non-melanoma skin cancer(c44) are age-adjusted using the world standard population to compare globally 2) Estimated cancer incidence rate for 2012 using the cancer registration data by the year 2007 (GLOBOCAN 2012, IARC, 2013) * Ranked by the order of age-standardized rates

17 International Comparison of Age-Standardized Incidence Rates: Female Rank * Korea 1) (2014) Estimated rates (2012) 2) Japan USA UK All Cancers All Cancers All Cancers All Cancers Excluding Thyroid Excluding Thyroid Excluding Thyroid Excluding Thyroid Thyroid 69.8 Breast 51.5 Breast 92.9 Breast Breast 47.7 Colon and rectum 23.5 Lung 33.7 Lung Colon and rectum 23.0 Stomach 16.5 Colon and rectum 22.0 Colon and rectum Stomach 21.4 Lung 12.9 Thyroid 20.0 Melanoma of skin Lung 14.9 Cervix uteri 10.9 Corpus uteri 19.5 Corpus uteri Cervix uteri 9.0 Corpus uteri 10.6 Melanoma of skin 12.6 Ovary Liver 8.6 Ovary 8.4 Non-Hodgkin 10.2 Non-Hodgkin 8.5 Lymphoma Lymphoma 8 Ovary 6.4 Pancreas 6.7 Kidney 8.5 Cervix uteri Non-Hodgkin Lymphoma 10 Corpus uteri Thyroid 6.5 Ovary 8.0 Leukemia 5.8 Non-Hodgkin Lymphoma (Unit: rate per 100,000) 5.9 Leukemia 7.1 Kidney 5.8 1) The incidence rates of all cancers excluding non-melanoma skin cancer(c44) are age-adjusted using the world standard population to compare globally 2) Estimated cancer incidence rate for 2012 using the cancer registration data by the year 2007 (GLOBOCAN 2012, IARC, 2013) * Ranked by the order of age-standardized rates

18 Cancer Survival in Korea, 2014 Subjects: 2,813,643 cancer cases diagnosed between January 1, 1993 and December 31, 2014 Follow-up: Through December 31, 2015

19 Trends in Five-Year Relative Survival by Sex: All cancers

20 Trends in Five-Year Relative Survival by Sex: Excluding Thyroid

21 Five-Year Survival of Major Cancer Sites 1) : Both sexes 1) Major sites selected based on 2014 crude rates * difference in the cancer survival probability between '93~'95 and 10~'14

22 Five-Year Survival of Major Cancer Sites 1) : Male 1) Major sites selected based on 2014 crude rates * difference in the cancer survival probability between '93~'95 and 10~'14

23 Five-Year Survival of Major Cancer Sites 1) : Female 1) Major sites selected based on 2014 crude rates * difference in the cancer survival probability between '93~'95 and 10~'14

24 Cancer Sites International Comparison of Five-Year Relative Survival Korea ( 96-00) Korea ( 01-05) Korea ( 10-14) USA 1) ( 06-12) Canada 2) ( 06-08) (Unit: %) Japan 3) ( 06-08) All cancers Thyroid Stomach Colon and rectum Lung Breast Liver Prostate Pancreas Cervix uteri ) Howlader N, et al. SEER Cancer Statistics Review, , National Cancer Institute. Bethesda, MD, based on November 2015 SEER data submission, posted to the SEER web site, April ) Canadian Cancer Society, Statistics Canada and Provincial/Territorial Cancer Registry. Canadian Cancer Statistics ) Center for Cancer Control and Information Services, National Cancer Center, Monitoring of Cancer Incidence in Japan - Survival report 2016

25 Cancer Prevalence in Korea, 2014 Definition of cancer prevalence counts: - Cancer prevalence represents the people who are alive on January 1, 2015 among the patients who were diagnosed with cancer between January 1, 1999 and December 31, 2014 (limited-duration prevalence), which includes new and pre-existing cancer patients diagnosed during a given time period still alive on January 1, Multiple primary cancer cases are counted multiple times.

26 Distribution of Cancer Prevalence, 2014

27 Distribution of Cancer Prevalence by Sex, 2014

28 Prevalence of All Cancers by Time since Diagnosis *, 2014 * People who are alive on January 1, 2015 among the cancer patients who were diagnosed between January 1, 1999 and December 31, 2014

29 Prevalence of the Major Cancer Sites by Time since Diagnosis, 2014 Time since diagnosis Thyroid Stomach Colon and rectum Breast Lung Prostate Liver Cervix uteri Kidney Non- Hodgkin lymphoma All cancers Under 1 year 30,635 26,812 24,674 18,144 16,808 9,526 11,491 3,331 4,141 4, , years 42,457 24,241 22,870 16,888 10,208 8,858 8,162 3,187 3,713 3, , years 120,630 65,813 61,623 43,990 17,890 21,992 17,409 9,158 9,307 8, ,505 More than 5 years 134, ,306 93,128 79,894 18,554 21,880 20,629 29,513 14,449 14, ,155 Total 328, , , ,916 63,460 62,256 57,691 45,189 31,610 31,553 1,464,935

30 Thank you